news
01-29-2015, 02:52 AM
The study found evidence of “adverse tiering,” or placing all of the drugs used to treat H.I.V. in a specialty tier, where consumers are required to pay at least 30 percent of the cost of the drug.http://rss.nytimes.com/c/34625/f/642562/s/42d05b50/sc/36/mf.gif
More... (http://rss.nytimes.com/c/34625/f/642562/s/42d05b50/sc/36/l/0L0Snytimes0N0C20A150C0A10C290Cbusiness0Cstudy0Efi nds0Ehiv0Edrugs0Epriced0Eout0Eof0Ereach0Bhtml0Dpar tner0Frss0Gemc0Frss/story01.htm)
More... (http://rss.nytimes.com/c/34625/f/642562/s/42d05b50/sc/36/l/0L0Snytimes0N0C20A150C0A10C290Cbusiness0Cstudy0Efi nds0Ehiv0Edrugs0Epriced0Eout0Eof0Ereach0Bhtml0Dpar tner0Frss0Gemc0Frss/story01.htm)